Saturday, April 26, 2025
HomeTagsHealthcare

Healthcare

Innovent Announces First Patient Dosing of Universal “Modular” CAR-T Cell product IBI345

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune...

Black Women in Clinical Research Is Reshaping the Industry as Drastic Change to Clinical Research Occurs

Black Women in Clinical Research and its affiliate organizations, Black Men in Clinical Research and Minorities in Clinical Research, are becoming a growing force...

Synthego Raises $200 Million to Accelerate the Field of CRISPR-Based Medicines

Synthego, the genome engineering company, announced it has raised $200 million of growth capital, including a Series E financing led by Perceptive Advisors. Also...

PolarityTE Announces Allowance of Fourth U.S. Patent

PolarityTE, Inc. , a biotechnology company developing regenerative tissue products and biomaterials, announced the U.S. Patent and Trademark Office (USPTO) recently issued a Notice...

Gracell Biotechnologies Doses First Patients in First-in-Human Clinical Trial Evaluating

Gracell Biotechnologies Inc., a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, announced that...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics